SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antibe Therapeutics Inc.
ATE.TO 1.160+0.9%Oct 13 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Sultan8/2/2019 2:30:52 AM
1 Recommendation

Recommended By
ogi

   of 15
 
Top Pick

Market cap of $69 million. Pain medications create stomach upset. They produce a coating to counteract that. They are also working on a non-steroid anti-inflammatory drug in the US. They are testing it on over 350 patients in 35 different facilities. This would put them into an $11 billion US market if successful. The results are expected in end-September. There is a 5 times upside potential here. A speculative buy. Yield 0% (Analysts’ price target is $1.45)


stockchase.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News